A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
Is a
Allocation Type
NA
0
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Intervention Name
PTC923
0
Interventional Trial Phase
Phase 3
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Drug
0
Last Updated
December 8, 2023
0
Masking Type
None (Open Label)
0
Primary Completion Date
February 7, 2025
0
Trial Recruitment Size
200
0
Trial Sponsor
Clinical Trial Start Date
February 14, 2022
0
Study Completion Date
February 7, 2025
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
0
Official Website
Find more entities like A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.